Autologous Transplant in HIV Patients (BMT CTN 0803)
Public ClinicalTrials.gov record NCT01141712. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803)
Study identification
- NCT ID
- NCT01141712
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Medical College of Wisconsin
- Other
- Enrollment
- 43 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 15 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2010
- Primary completion
- Apr 30, 2015
- Completion
- May 31, 2016
- Last update posted
- Jan 3, 2023
2010 – 2016
United States locations
- U.S. sites
- 16
- U.S. states
- 8
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope National Medical Center | Duarte | California | 91010-3000 | — |
| University of California San Diego Medical Center | La Jolla | California | 92093 | — |
| UCLA | Los Angeles | California | 90035 | — |
| University of CA, SF | San Francisco | California | 94143 | — |
| University of Florida College of Medicine | Gainesville | Florida | 32610 | — |
| H. Lee Moffitt Cancer Center | Tampa | Florida | 33624 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| BMT Program at Northside Hospital | Atlanta | Georgia | 30342 | — |
| University of Maryland Medical Systems, Greenebaum Cancer Center | Baltimore | Maryland | 21201 | — |
| Johns Hopkins Medical Institution | Baltimore | Maryland | 21231 | — |
| Washington University/Barnes Jewish Hospital | St Louis | Missouri | 63110 | — |
| Weill Cornell Medical College | New York | New York | 10065 | — |
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10174 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| Ohio State University Medical Center | Columbus | Ohio | 43210 | — |
| University of Texas/MD Anderson Cancer Center | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01141712, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 3, 2023 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01141712 live on ClinicalTrials.gov.